Acquired immunodeficiency syndrome (AIDS)--apheresis and operative risks.

abstract：:Staphylococcal protein A efficiently binds immunoglobulins and circulating immune complexes (CIC) and provides an effective medium to remove immunoglobulins and CICs from plasma while sparing albumin and most coagulation proteins. Although it activates the complement system its clinical use abrogates the need for plas...

journal_title：Journal of clinical apheresis

authors： Howe RB,Christie DJ

更新日期：1994-01-01 00:00:00

abstract：:Plasma replacement for thrombotic thrombocytopenic purpura (TTP) is accomplished with various plasma products. This study sought to determine the incidence of allergic reactions with FFP or CPP as replacement in therapeutic plasma exchange (TPE). Forty-one TTP patients were identified retrospectively who received TPE ...

journal_title：Journal of clinical apheresis

authors： Reutter JC,Sanders KF,Brecher ME,Jones HG,Bandarenko N

更新日期：2001-01-01 00:00:00

abstract：BACKGROUND/AIMS:High-volume plasma exchange (HVPE), defined as an exchange of 8 to 12 L per day per procedure or 15% of the ideal body weight with fresh frozen plasma, has shown promising results in improving the survival of patients with acute liver failure (ALF). However, clinical evidence is limited. The aim of this...

journal_title：Journal of clinical apheresis

authors： Kim JE,Chun S,Sinn DH,Kim NJ,Kim S,Kang W,Kim JM,Choi GS,Joh JW,Cho D

更新日期：2021-01-05 00:00:00

abstract：:Complement-derived anaphylatoxin may be one of the causes of vascular injury and an indicator of activity in systemic lupus erythematosus (SLE). The present study examines the effectiveness of dextran sulfate (DS) column immunoadsorption treatment to remove anaphylatoxins (C3a, C4a, and C5a) from the blood of patients...

journal_title：Journal of clinical apheresis

authors： Matsuki Y,Suzuki K,Kawakami M,Ishizuka T,Hidaka T,Nakamura H

更新日期：1998-01-01 00:00:00

abstract：:Either bone marrow or peripheral blood may be harvested to provide hematopoietic stem cells (HSC) for autologous transplantation. Both, however, comprise heterogeneous cell populations. The HSC necessary for successful engraftment constitute a very small fraction of the cells harvested. After collection, the harvested...

journal_title：Journal of clinical apheresis

authors： Rowley SD

更新日期：1992-01-01 00:00:00

abstract：:Modern techniques of mechanical hemapheresis have made it possible to selectively remove vast quantities of lymphocytes and plasma immunoglobulins, and the concentration of these substances in donor blood can fall below the normal range. It is feared that this may lead to immunosuppression; a condition associated in s...

journal_title：Journal of clinical apheresis

authors： Strauss RG

更新日期：1984-01-01 00:00:00

abstract：BACKGROUND AND OBJECTIVES:Estimation of the total blood volume (TBV) is fundamental to the control of automated red cell exchange (RCE). Error in the TBV estimate can produce outcomes that deviate from the prescribed targets, and may endanger the patient. Both the Spectra Optia and the COBE Spectra use the Nadler formu...

journal_title：Journal of clinical apheresis

authors： Colavita D,Kim HC,Friedman DF

更新日期：2019-12-01 00:00:00

abstract：:Thrombotic thrombocytopenic purpura (TTP) is a rare but severe disorder characterized by hemolytic anemia, thrombocytopenia, fever, renal failure, and neurologic manifestations. Plasma exchange is the most effective treatment for this condition reducing mortality from 90% in untreated patients to 10%. However, infecti...

journal_title：Journal of clinical apheresis

authors： Illoh OC

更新日期：2007-01-01 00:00:00

abstract：BACKGROUND:Patients undergoing therapeutic plasma exchange (TPE) may present with risks for hemorrhage or thrombosis. Use of replacement fluids devoid of coagulation factors will decrease factor levels and platelet levels. There are no established guidelines for hemostasis management in these situations. MATERIALS AND...

journal_title：Journal of clinical apheresis

authors： Zantek ND,Boral LI,Li Y,Yamada C,Svensson AM,Crane JE,Smith RE,Pagano MB,Rollins-Raval MA,Schmidt AE,Wong ECC,Wu Y

更新日期：2018-10-01 00:00:00

abstract：:Recently very potent extracorporeal cholesterol-lowering treatment options have become available for patients with hypercholesterolemia. LDL immunoapheresis treatment selectively removes LDL and lipoprotein(a) from the circulation. Since LDL is the major carrier of lipophilic antioxidants in plasma, the purpose of the...

journal_title：Journal of clinical apheresis

authors： Cauza E,Jansen M,Resch U,Dunky A,Derfler K,Winklhofer-Roob BM,Kostner K

更新日期：2004-01-01 00:00:00

abstract：:This is an attempt at comparing two cell separators for plateletpheresis, namely the Fresenius AS.TEC 204 and Haemonetics MCS 3p, at a tertiary care center in India. Donors who weighed between 55-75 kg, who had a hematocrit of 41-43%, and platelet counts of 250x10(3)-400x10(3)/microl were selected for the study. The c...

journal_title：Journal of clinical apheresis

authors： Ranganathan S

更新日期：2007-02-01 00:00:00

abstract：:Transfusion-acquired babesiosis can be an asymptomatic or self-limited febrile hemolytic illness in a healthy host. A persistent, relapsing, and/or fulminant course with the development of life-threatening complications may be seen in immunocompromised or splenectomized patients. As in malaria, erythrocyte parasitemia...

journal_title：Journal of clinical apheresis

authors： Herman JH,Ayache S,Olkowska D

更新日期：2010-01-01 00:00:00

abstract：:Extra-corporeal photopheresis (ECP) is known as safe ultimate treatment option for chronic lung allograft dysfunction (CLAD). Here, we report the first case of ECP as "second-line" immunomodulatory therapy early post-transplant in an adult patient undergoing lung transplantation for severe chronic thromboembolic pulmo...

journal_title：Journal of clinical apheresis

authors： Steinack C,Robinson CA,Nägeli M,Inci I,Benden C

更新日期：2020-08-24 00:00:00

abstract：:We have reviewed our initial experience with a program of concurrent collection of plasma (CCP) during plateletpheresis, which was instituted to increase the number of units of fresh frozen plasma produced by our hospital-based donor service. Sixty percent of eligible donors (1,006 of 1,682) participated in CCP, and 2...

journal_title：Journal of clinical apheresis

authors： Burger SR,Thomas BT,Grishaber JE

更新日期：1994-01-01 00:00:00

abstract：:The removal of specific antibody in experimental animals has been reported to result in a subsequent increase in antibody to levels equal to (rebound) or exceeding those existing prior to removal (overshoot). Anecdotal reports suggest that rebound antibody synthesis after plasmapheresis may occur in humans with autoim...

journal_title：Journal of clinical apheresis

authors： Nasca TJ,Muder RR,Thomas DB,Schrecker JC,Ruben FL

更新日期：1990-01-01 00:00:00

abstract：BACKGROUND:Autologous stem cell transplantation (auto-SCT) is a treatment approach in non-Hodgkin lymphoma (NHL) patients. The options for mobilization of CD34+ cells to support high-dose therapy are granulocyte-colony stimulating factors (G-CSFs) alone or after chemotherapy. Limited data exist on the efficacy of lipeg...

journal_title：Journal of clinical apheresis

authors： Partanen A,Turunen A,Valtola J,Vasala K,Ågren L,Penttilä K,Pyörälä M,Kuittinen T,Mäntymaa P,Pelkonen J,Jantunen E,Varmavuo V

更新日期：2020-08-01 00:00:00

abstract：INTRODUCTION:ABO- or HLA-incompatible kidney transplantation is possible thanks to pretransplant antibody-depletion achieved by extracorporeal-treatment modalities. These methods induce depletion of some plasma proteins and may also impact on proteins involved in hemostasis. METHODS:To determine the impact of one sess...

journal_title：Journal of clinical apheresis

authors： Marlu R,Bennani HN,Seyve L,Malvezzi P,Janbon B,Noble J,Christophe M,Motte L,Imerzoukene F,Chevallier E,Rostaing L,Jouve T

更新日期：2020-08-17 00:00:00

abstract：BACKGROUND:Transfusion of D+ red blood cells (RBCs) to D- recipients can be accidental or necessary due to D- RBC shortage. Alloimmunization can complicate future transfusions; implications for women of childbearing age are compounded by possible hemolytic disease of the fetus and newborn. Rh immunoprophylaxis is effec...

journal_title：Journal of clinical apheresis

authors： Werch JB

更新日期：2010-01-01 00:00:00

abstract：:The practice of transfusing ABO-incompatible platelets, driven primarily by concerns about inventory management, has been considered generally safe because the accompanying plasma is usually diluted in the recipient's total blood volume. However, if the platelet product contains a large volume of plasma or a high conc...

journal_title：Journal of clinical apheresis

authors： Sapatnekar S,Sharma G,Downes KA,Wiersma S,McGrath C,Yomtovían R

更新日期：2005-12-01 00:00:00

abstract：BACKGROUND:Plasma exchange (PE) and double filtration plasmapheresis (DFPP) are known as effective treatment options for hyperviscosity syndrome (HVS) caused by Waldenstrom macroglobulinemia. Nonetheless, few data are available for the relation between the prescribed dose of apheresis and the reduction rate of target m...

journal_title：Journal of clinical apheresis

authors： Miyamoto Y,Hamasaki Y,Matsumoto A,Doi K,Noiri E,Nangaku M

更新日期：2018-10-01 00:00:00

abstract：:Prestorage leukocyte reduction of platelet concentrates may reduce adverse effects of transfusion while affording better quality control. Platelets and leukocytes may undergo activation during storage, which could affect the performance of leukocyte reduction filters. The purpose of this study was to evaluate the effi...

journal_title：Journal of clinical apheresis

authors： Jin YS,Mintz PD

更新日期：1997-01-01 00:00:00

abstract：:We describe the case of a 24 year old male with severe fistulating Crohn's disease who failed mutliple modalities of medical and surgical therapy. We present objective and subjective evidence of disease remission after induction and maintenance treatment with leukocyte apheresis. This is the first described case of su...

journal_title：Journal of clinical apheresis

authors： Tate D,Cairnes V,Valori R,Makins R

更新日期：2014-06-01 00:00:00

abstract：:Management of aTTP in patients who refuse or are intolerant to plasma remains challenging, but new drugs can be implemented with success. A 39-year-old woman presented to the Emergency department for bruises at the upper and lower limbs together with worsening anemia and thrombocytopenia; PLASMIC score was seven, indi...

journal_title：Journal of clinical apheresis

authors： Perrone S,Passucci M,Ortu La Barbera E,Capriata M,Ferretti A,Mecozzi A,Giovangrossi P,Equitani F,Cimino G

更新日期：2021-01-18 00:00:00

abstract：:Therapeutic plasma exchange (TPE), a form of extracorporeal therapy, has been used in the management of many systemic conditions some of which include the systemic vasculitides that affect the kidneys. The following is a mini review of what is known about renal related indications for TPE in such conditions and the ev...

journal_title：Journal of clinical apheresis

authors： Balogun RA,Abdel-Rahman EM

更新日期：2011-01-01 00:00:00

abstract：:Thrombotic thrombocytopenic purpura (TTP) is a condition caused by deficiency of ADAMTS13 resulting in accumulation of ultra large Von Willebrand factor multimers (ULVWF), leading to micro thrombi in multiple organs. The varying susceptibilities of blood group antigens to ADAMTS13 have been demonstrated. A and B antig...

journal_title：Journal of clinical apheresis

authors： Zuberi L,Yerasuri D,Kuriakose P

更新日期：2009-01-01 00:00:00

abstract：:Current management of heparin-induced thrombocytopenia (HIT) involves prompt discontinuation of all heparin products and concomitant initiation of a direct thrombin or anti-Xa inhibitor for anticoagulation. In the setting of HIT complicated by an urgent need for cardiopulmonary bypass (CPB), the safety and the efficac...

journal_title：Journal of clinical apheresis

authors： Cho JH,Parilla M,Treml A,Wool GD

更新日期：2019-02-01 00:00:00

abstract：BACKGROUND:There are several regimens used in hematopoietic stem cell (HSC) mobilization in multiple myeloma (MM). Cyclophosphamide (Cy) is one of the most commonly used agents, although it does not always result in collecting adequate number of CD34+ cells. Recently, cytarabine (Ara-C) has been proposed as potentially...

journal_title：Journal of clinical apheresis

authors： Bogucka-Fedorczuk A,Czyz A,Kalicińska E,Sawicki M,Laszkowska-Lewko M,Wicherska-Pawłowska K,Rybka J,Szeremet A,Prajs I,Szymczak D,Wróbel T

更新日期：2020-08-01 00:00:00

abstract：:Therapeutic leukapheresis can control the white blood cell count (WBC) of pregnant women with chronic myelogenous leukemia (CML) who have hyperleukocytosis without leukostasis. The medical justification for this treatment has not been objectively documented. We report a 27-year-old woman, diagnosed with CML at 10-week...

journal_title：Journal of clinical apheresis

authors： Galera P,Haynes S,Sulmasy P,Bailey JA,Greene M,Vauthrin M,Brettler D,Liebmann J,Mark Madison J,Weinstein R

更新日期：2016-08-01 00:00:00

abstract：:Focal segmental glomerulosclerosis (FSGS) recurs in 30% of renal allograft transplants with graft loss in half of the cases. A humoral factor may be implicated. We report on the use of therapeutic plasma exchange (TPE) in 11 patients with recurrent FSGS post transplantation. Medical records from 1989-2000 were reviewe...

journal_title：Journal of clinical apheresis

authors： Shariatmadar S,Noto TA

更新日期：2002-01-01 00:00:00

abstract：:During the course of heparin-induced extracorporeal lipoprotein apheresis, a patient with no prior known renal impairment or proteinuria demonstrated sustained improvement in estimated glomerular filtration rate, commensurate with reduction in serum lipids and creatine phosphokinase levels. Causes and implications of ...

journal_title：Journal of clinical apheresis

authors： Chandran PK

更新日期：2011-01-01 00:00:00